<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00829543</url>
  </required_header>
  <id_info>
    <org_study_id>8715</org_study_id>
    <nct_id>NCT00829543</nct_id>
  </id_info>
  <brief_title>Unguided Sacroiliac Injection: Effect on Refractory Buttock Pain in Patients With Spondyloarthropathies</brief_title>
  <official_title>Guide-Free Sacroiliac Injection in Spondyloarthropathies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tabriz University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tabriz University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to evaluate the efficacy and safety of guide-free sacroiliac joint
      (SIJ) injection in refractory sacroiliac pain due to spondyloarthropathies.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A 20 weeks open-label clinical trial study of 35 patients, with different subtypes of
      spondyloarthropathies, is conducted In spondyloarthropathy's patients with refractory
      inflammatory buttock pain (fulfilling inclusion criteria), we performed outpatient guide-free
      sacroiliac injection of triamcinolone acetonide 40 mg in each joint. Patient (pain,
      stiffness, sleep disturbance) and Clinician assessments (sacroiliac tenderness, Finger to
      floor and Schober tests ) are recorded at baseline and every 4 weeks until the end of the
      study. MRI scoring of sacroiliac joint is recorded according to the Spondyloarthritis
      Research Consortium of Canada (SPARCC) magnetic resonance imaging (MRI) index for scoring
      inflammatory lesions in the sacroiliac joints, at baseline and in the end of the study.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Enrolling by invitation</last_known_status>
  <start_date>September 2004</start_date>
  <completion_date type="Anticipated">February 2009</completion_date>
  <primary_completion_date type="Actual">January 2007</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Refractory inflammatory sacroiliac pain</measure>
    <time_frame>8 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>ESR, CRP</measure>
    <time_frame>8 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient's assessment of: pain, sleep disturbance, morning stiffness</measure>
    <time_frame>8 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinician assessment of: SIJ pain, change of finger to floor (cm) and Schober tests (mm)</measure>
    <time_frame>8 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MRI SIJ inflammatory scoring</measure>
    <time_frame>8 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">35</enrollment>
  <condition>Spondylarthropathy</condition>
  <arm_group>
    <arm_group_label>sacroiliac injection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>an open label study designed to evaluate the efficacy and safety of guide-free sacroiliac injection in refractory sacroiliac pain due to spondyloarthropathies</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>guide-free sacroiliac corticosteroid injection</intervention_name>
    <description>guide-free sacroiliac injection of triamcinolone acetonide 40 mg in each sacroiliac joint</description>
    <arm_group_label>sacroiliac injection</arm_group_label>
    <other_name>Unguided sacroiliac injection</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients had to fulfill the European Spondylarthropathy Study Group criteria for SpA.

          1. The presence of inflammatory buttock pain for at least 4 months (typical night pain
             and morning stiffness) despite of receiving NSAIDs, corticosteroid and DMARDs (Disease
             Modifying Anti-Rheumatic Drugs) such as: methotrexate, sulfasalazin and azathioprine.

          2. Tenderness over sacroiliac joint: pain over the sacroiliac sulcus with 4-5 kg/cm2
             direct pressure.

        Exclusion Criteria:

          1. Spinal infections (such as Brucellosis).

          2. Local infection in the site of injection.

          3. Sacroiliac ankylosis based on pelvic X-Ray (sacroilitis grade IV).

          4. Patients who had received anti TNF, corticosteroid pulse or an investigational drugs
             during 4 months before.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shahram Sadreddini, Rheumatology</last_name>
    <role>Study Director</role>
    <affiliation>Tabriz medical university (Rheumatology Department)</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Shahram Sadreddini, Rheumatology</last_name>
    <role>Study Chair</role>
    <affiliation>Assistant professor of Tabriz medical university</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mahshid Molaeefard, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tehran medical university</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Seyed-Kazem Shakouri, Physiatrist</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistant professor of Tabriz medical university</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Morteza Ghojazadeh, Physiologist</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistant professor of Tabriz medical university</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hamid Noshad, Nephrologist</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistant professor of Tabriz medical university</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mohammad-Reza Ardalan, Nephrologist</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistant professor of Tabriz medical university</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Tabriz Medical University, Rheumatology Department</name>
      <address>
        <city>Tabriz</city>
        <state>East Azarbayjan</state>
        <zip>+989123355170</zip>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>February 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 26, 2009</study_first_submitted>
  <study_first_submitted_qc>January 26, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 27, 2009</study_first_posted>
  <last_update_submitted>February 2, 2009</last_update_submitted>
  <last_update_submitted_qc>February 2, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 3, 2009</last_update_posted>
  <responsible_party>
    <name_title>Dr Shahram Sadreddini, Assistant professor of Rheumatology</name_title>
    <organization>Tabriz university (medical sciences)</organization>
  </responsible_party>
  <keyword>Spodyloarthropathy</keyword>
  <keyword>Guide-free sacroiliac injection</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spondylarthropathies</mesh_term>
    <mesh_term>Spondylarthritis</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>February 5, 2009</submitted>
    <submission_canceled>Unknown</submission_canceled>
    <submitted>February 13, 2009</submitted>
    <returned>March 10, 2009</returned>
    <submitted>March 12, 2009</submitted>
    <returned>April 14, 2009</returned>
    <submitted>May 4, 2009</submitted>
    <returned>June 22, 2009</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

